Edge Animal Health
- Company typePrivate
- Founded2019
- HeadquartersNew Jersey, Trinidad & Tobago
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
Edge Animal Health firmographics
Firmographics- Name
- Edge Animal Health
- Legal name
- Edge Animal Health, Inc
- Website
- https://edgeanimalhealth.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Ownership category
- akta.pro rank
Where Edge Animal Health is headquartered
LocationHeadquarters
- HQ city
- New Jersey
- HQ country
- Trinidad & Tobago
- HQ region
- Latin America
Markets served
Edge Animal Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure
Marketing channels1 record
Edge Animal Health product offering
Product offeringCore offering
Edge Animal Health is a pre-commercial animal health biotechnology company developing novel therapeutics and vaccines for farm animals and companion animals. Its pipeline is built on gene-engineered vaccines (molecularly attenuated live, live vectored, non-replicating, and mRNA), gene and cell-based therapeutics, and stem cell therapies derived from iPSCs, MSCs, and endocrine cells. Underpinning platforms include an exclusively licensed CRISPR hybrid RNA-DNA (chRDNA) editing platform and advanced delivery technologies (viral vectors, bacterial vectors, encapsulation).
Product overview
Edge Animal Health is developing a bi-directional pipeline of novel biotechnological products for veterinary medicine. The core portfolio includes Gene Engineered Vaccines (molecularly attenuated live vaccines, vectored vaccines, and non-replicating vaccines) targeting farm animal health and antibiotic reduction, and Gene Engineered Therapeutics using cell and gene-based platforms enhanced with genetic engineering. The company also develops Stem Cell Therapies derived from iPSCs, MSCs, and endocrine cells for companion animal metabolic and endocrine diseases. Underpinning these products is the CRISPR chRDNA Platform for precision genome editing and Delivery Technologies (viral vectors, bacterial vectors, encapsulation) that enable effective administration of therapeutics and vaccines.
Differentiator
Problem solved
Functional benefit
Products and services
- Gene Engineered Vaccines
Companies that use Edge Animal Health
Customer profileSegments2 records
Ideal customer profiles2 records
Edge Animal Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Edge Animal Health partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered major and core.
- Bill & Melinda Gates FoundationmajorCollaborator and partner. The Gates Foundation supports global health initiatives and Edge's work aligns with their mission to improve animal health in developing regions. Nick Juleff, Ph.D., BVSc, MRCVS, FRSB, Senior Program Officer at the Gates Foundation, serves as an advisor to Edge.
- Caribou BiosciencescoreExclusive license agreement for CRISPR hybrid RNA-DNA (chRDNA) platform for veterinary medicine applications. Ruhi Khan, Chief Business Officer at Caribou Biosciences, serves on Edge's Board of Directors.
- University of GeorgiacoreAcademic research collaborator through University of Georgia Research Foundation (ugarf).
- University of MissouricoreAcademic research collaborator. John Dodam, DVM, MS, Ph.D., DACVAA, Professor and Chair, Department of Veterinary Medicine and Surgery at University of Missouri, serves as an advisor to Edge.
- Broad InstitutemajorAcademic research collaborator providing access to cutting-edge genomic research and capabilities.
- University of DelawarecoreAcademic research collaborator supporting Edge's biotechnology development programs.
- University of FloridacoreAcademic research collaborator contributing to Edge's pipeline development.
- NC State UniversitycoreAcademic research collaborator supporting Edge's biotechnology research initiatives.
Recent moves6 records
Expansion highlights5 records
Edge Animal Health competitors and assessment
Company assessmentMarket position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
Edge Animal Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Edge Animal Health leadership team
Management profileNumber of profiles
Profiles14 records
Edge Animal Health funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Edge Animal Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Edge Animal Health
What does Edge Animal Health do?
Edge Animal Health is a pre-commercial animal health biotechnology company developing novel therapeutics and vaccines for farm animals and companion animals. Its pipeline is built on gene-engineered vaccines (molecularly attenuated live, live vectored, non-replicating, and mRNA), gene and cell-based therapeutics, and stem cell therapies derived from iPSCs, MSCs, and endocrine cells. Underpinning platforms include an exclusively licensed CRISPR hybrid RNA-DNA (chRDNA) editing platform and advanced delivery technologies (viral vectors, bacterial vectors, encapsulation).
Is Edge Animal Health a public or private company?
Edge Animal Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Edge Animal Health founded?
Edge Animal Health was founded in 2019.
Where is Edge Animal Health based?
Edge Animal Health is headquartered in New Jersey, Trinidad & Tobago, in the Latin America region.
Does Edge Animal Health have an API?
No public API is recorded for Edge Animal Health.